AT&T, Amdocs open Ra’anana innovation center

The Ra’anana center is the second permanent AT&T Foundry facility to open worldwide.

June 15, 2011 23:49
1 minute read.
Amdocs CEO Eli Gelman

Gelman 311. (photo credit: Natan Dvir)

American telecommunications giant AT&T on Wednesday opened its latest foundry innovation center in Ra’anana, together with Amdocs.

The Ra’anana center is the second permanent AT&T Foundry facility to open worldwide. It replaces a temporary facility where dozens of collaborative projects have been under way since AT&T and Amdocs announced plans to collaborate last July.

Be the first to know - Join our Facebook page.

This follows the opening of a center in Plano, Texas, not far from AT&T’s global headquarters in Dallas, in February.

Work is also under way in two separate temporary facilities in Silicon Valley and San Francisco, with a permanent center hosted by Ericsson to open later this year in Palo Alto, California.

In Ra’anana, AT&T and technology providers will work with start-ups and developers to get the latest innovations and services into the hands of customers more quickly than ever before, the company said in a press release. Projects there already enable integrated mobile and wired broadband capabilities crossing multiple screens, including smartphones, PCs, televisions and emerging devices, it said.

“The AT&T Foundry network is a collaborative environment where AT&T researchers, key industry technology providers and developers from all over the world innovate in new ways,” AT&T CTO John Donovan said. “Project managers drive project development in 30- and 90- day sprints that allow us to cut the time required to evolve great ideas into products and services by twothirds.”

Amdocs CEO Eli Gelman said: “The team in Ra’anana has deep ties with the start-up community and specializes in identifying unique technologies that can benefit AT&T and their customers. It offers start-ups and developers the environment to initiate and advance projects by providing technological expertise to make their idea happen.”

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection